Lataa...
Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...
Tallennettuna:
| Julkaisussa: | Gastroenterol Rep (Oxf) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434590/ https://ncbi.nlm.nih.gov/pubmed/32843973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa018 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|